Supplementary Figures 1-3 and Table1 from Nanobody Targeting of Epidermal Growth Factor Receptor (EGFR) Ectodomain Variants Overcomes Resistance to Therapeutic EGFR Antibodies

Abstract

<p>Supplementary Figure 1 shows Nanobody 7D12 block of different EGFR ligands; Supplementary Figure 2 shows EGFR expression and EGF stimulated growth of mutated EGFR variants; Supplementary Figure 3 shows phage display experiments; Supplementary Table 1 shows EGFR primers.</p>